Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?

The Lancet

Volumn 384, Issue 9940, 2014, Pages 347-370

  Bhutta, Zulfiqar A ^a,b   Das, Jai K ^b   Bahl, Rajiv ^c   Lawn, Joy E ^d,e,f   Salam, Rehana A ^b   Paul, Vinod K ^g   Sankar, M Jeeva ^g   Blencowe, Hannah ^d   Rizvi, Arjumand ^b   Chou, Victoria B ^h   Walker, Neff ^h  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e SAVE THE CHILDREN   (United States)

^f Research and Evidence Division   (United Kingdom)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH; CHILD CARE; HEALTH CARE COST; HUMAN; LABOR; MATERNAL CARE; MATERNAL MORTALITY; NEWBORN DEATH; PRIORITY JOURNAL; STILLBIRTH; ALLOIMMUNIZATION; COST; DELIVERY; FEMALE; HEALTH PROMOTION; MALNUTRITION; MATERNAL HYPERTENSION; META ANALYSIS (TOPIC); NEWBORN; NEWBORN CARE; NEWBORN MORTALITY; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; POSTNATAL CARE; PREGNANCY; PRENATAL PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TOTAL QUALITY MANAGEMENT;

FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INFANT MORTALITY; MATERNAL HEALTH SERVICES; MATERNAL MORTALITY; PERINATAL CARE; PREGNANCY; PREVENTIVE MEDICINE; QUALITY IMPROVEMENT; STILLBIRTH;

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; EMOLLIENT AGENT; INDOMETACIN; INFLUENZA VACCINE; MAGNESIUM SULFATE; STEROID;

EID: 84904857686     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60792-3     Document Type: Review

References (143)

1. Lawn JE, Blencowe H, Oza S, et al, for The Lancet Every Newborn Study Group. Progress, priorities, and potential beyond survival. Lancet 2014; published online May 20. http://dx.doi.org/10.1016/S0140-6736(14)60496-7.
2. Lawn JE, Blencowe H, Pattinson R, et al, and The Lancet's Stillbirths Series steering committee. Stillbirths: Where? When? Why? How to make the data count? Lancet 2011; 377: 1448-63.
3. Darmstadt GL, Kinney MV, Chopra M, et al, for The Lancet Every Newborn Study Group. Who has been caring for the baby? Lancet 2014; published online May 20. http://dx.doi.org/10.1016/S0140-6736(14)60458-X.
4. Bhutta ZA, Yakoob MY, Lawn JE, et al, and The Lancet's Stillbirths Series steering committee. Stillbirths: what difference can we make and at what cost? Lancet 2011; 377: 1523-38.
5. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L, and the Lancet Neonatal Survival Steering Team. Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet 2005; 365: 977-88.
6. Bhutta ZA, Ali S, Cousens S, et al. Alma-Ata: Rebirth and Revision 6 Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Lancet 2008; 372: 972-89.
7. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS; Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet 2003; 362: 65-71.
8. Bhutta ZA, Das JK, Rizvi A, et al, and the Lancet Nutrition Interventions Review Group, and the Maternal and Child Nutrition Study Group. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013; 382: 452-77.
9. Dean SV, Imam AM, Lassi ZS, Bhutta ZA. Importance of intervening in the preconception period to impact pregnancy outcomes. Nestle Nutr Inst Workshop Ser 2013; 74: 63-73.
10. Mehra S, Agrawal D. Adolescent health determinants for pregnancy and child health outcomes among the urban poor. Indian Pediatr 2004; 41: 137-45.
11. Haldre K, Rahu K, Karro H, Rahu M. Is a poor pregnancy outcome related to young maternal age? A study of teenagers in Estonia during the period of major socio-economic changes (from 1992 to 2002). Eur J Obstet Gynecol Reprod Biol 2007; 131: 45-51.
12. Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers? Arch Dis Child 2009; 94: 239-45.
13. WHO. Adolescent pregnancy: unmet needs and undone deeds. A review of literature and programmes. WHO Discussion Papers on Adolescence. Geneva: World Health Organization Department of Child and Adolescent Health and Development, 2007.
14. Ronnenberg AG, Wood RJ, Wang X, et al. Preconception hemoglobin and ferritin concentrations are associated with pregnancy outcome in a prospective cohort of Chinese women. J Nutr 2004; 134: 2586-91.
15. DiCenso A, Guyatt G, Willan A, Griffith L. Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. BMJ 2002; 324: 1426.
16. Oringanje C, Meremikwu MM, Eko H, Esu E, Meremikwu A, Ehiri JE. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2009; 4: CD005215.
17. Blank L, Baxter SK, Payne N, Guillaume LR, Pilgrim H. Systematic review and narrative synthesis of the effectiveness of contraceptive service interventions for young people, delivered in educational settings. J Pediatr Adolesc Gynecol 2010; 23: 341-51.
18. Blank L, Baxter SK, Payne N, Guillaume LR, Squires H. Systematic review and narrative synthesis of the effectiveness of contraceptive service interventions for young people, delivered in health care settings. Health Educ Res 2012; 27: 1102-19.
19. Lopez LM, Hiller JE, Grimes DA, Chen M. Education for contraceptive use by women after childbirth. Cochrane Database Syst Rev 2012; 8: CD001863.
20. Fedrick J, Adelstein P. Influence of pregnancy spacing on outcome of pregnancy. BMJ 1973; 4: 753-56.
21. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: A meta-analysis. JAMA 2006; 295: 1809-23.
22. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: A systematic review. Am J Obstet Gynecol 2007; 196: 297-308.
23. Lopez LM, Steiner M, Grimes DA, Hilgenberg D, Schulz KF. Strategies for communicating contraceptive eff ectiveness. Cochrane Database Syst Rev 2013; 4: CD006964.
24. Arrowsmith ME, Aicken CRH, Saxena S, Majeed A. Strategies for improving the acceptability and acceptance of the copper intrauterine device. Cochrane Database Syst Rev 2012; 3: CD008896.
25. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; 10: CD007950.
26. WHO. WHO Immunization, surveillance, assessment and monitoring. 2009. http://www.who.int/immunization-monitoring/en/globalsummary/scheduleselect.cfm (accessed Jan 20, 2014).
27. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol 2010; 39 (suppl 1): 102-09.
28. Eisele TP, Larsen D, Steketee RW. Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Int J Epidemiol 2010; 39 (suppl 1): 88-101.
29. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health 2011; 11 (suppl 3): S9.
30. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2008; 2: CD006178.
31. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; 1: CD000262.
32. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2013; 1: CD007467.
33. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007; 2: CD000490.
34. McCarthy FP, Giles ML, Rowlands S, Purcell KJ, Jones CA. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev 2011; 3: CD008371.
35. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008; 1: CD004946.
36. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev 2000; 3: CD001684.
37. Di Mario S, Basevi V, Gagliotti C, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev 2013; 2: CD006171.
38. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2011; 7: CD003510.
39. Newell M-L, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Curr Opin HIV AIDS 2013; 8: 504-10.
40. Ananth CV, Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiology 2010; 21: 118-23.
41. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health 2014; published online May 6. http://dx.doi.org/10.1016/S2214-109X(14)70227-X.
42. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007; 1: CD002252.
43. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010; 11: CD000025.
44. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; 2: CD004659.
45. Jabeen M, Yakoob MY, Imdad A, Bhutta ZA. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health 2011; 11 (suppl 3): S6.
46. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007; 34: 173-99, vii.
47. Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N, and the Northern Diabetic Pregnancy Survey Steering Group. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008; 115: 445-52.
48. Cheung NW, McElduff A, Ross GP. Type 2 diabetes in pregnancy: A wolf in sheep's clothing. Aust N Z J Obstet Gynaecol 2005; 45: 479-83.
49. Lassi ZS, Bhutta ZA. Risk factors and interventions related to maternal and pre-pregnancy obesity, pre-diabetesand diabetes for maternal, fetal and neonatal outcomes: A systematic review. Expert Rev Obstet Gynecol 2013; 8: 639-60.
50. WHO. Guideline. Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization, 2012.
51. Black RE, Victora CG, Walker SP, et al, and the Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382: 427-51.
52. Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol 2012; 26 (suppl 1): 138-52.
53. Fisk NM, Smith RP. Fetal growth restriction; small for gestational age. In: Chamberlain G, Steer P, eds. Turnbull's Obstetrics. London: Churchill Livingstone, 2001: 197-209.
54. Imdad A, Yakoob MY, Siddiqui S, Bhutta ZA. Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: A systematic review with a focus on reduction of IUGR related stillbirths. BMC Public Health 2011; 11 (suppl 3): S1.
55. Crowther CA, Middleton P, McBain RD. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2013; 2: CD000020.
56. Crowther C, Middleton P. Anti-D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2000; 2: CD000021.
57. Karanth L, Jaafar SH, Kanagasabai S, Nair NS, Barua A. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2013; 3: CD009617.
58. Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013; 74 (suppl 1): 86-100.
59. Rahman A, Fisher J, Bower P, et al. Interventions for common perinatal mental disorders in women in low- and middle-income countries: A systematic review and meta-analysis. Bull World Health Organ 2013; 91: 593-601.
60. Chowdhary N, Sikander S, Atif N, et al. The content and delivery of psychological interventions for perinatal depression by non-specialist health workers in low and middle income countries: A systematic review. Best Pract Res Clin Obstet Gynaecol 2014; 28: 113-33.
61. Hoff brand S, Howard L, Crawley H. Antidepressant drug treatment for postnatal depression. Cochrane Database Syst Rev 2001; 2: CD002018.
62. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010; 10: CD002059.
63. Osborn DA, Jeffery HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010; 10: CD002053.
64. Lavender T, Hart A, Smyth RM. Effect of partogram use on outcomes for women in spontaneous labour at term. Cochrane Database Syst Rev 2008; 4: CD005461.
65. Devane D, Lalor JG, Daly S, McGuire W, Smith V. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. Cochrane Database Syst Rev 2012; 2: CD005122.
66. Lee ACC, Cousens S, Darmstadt GL, et al. Care during labor and birth for the prevention of intrapartum-related neonatal deaths: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11 (suppl 3): S10.
67. Yakoob MY, Ali MA, Ali MU, et al. The effect of providing skilled birth attendance and emergency obstetric care in preventing stillbirths. BMC Public Health 2011; 11 (suppl 3): S7.
68. Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11 (suppl 3): S11.
69. Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol 2010; 39 (suppl 1): 122-33.
70. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3: CD004454.
71. Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for preterm pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. Int J Epidemiol 2010; 39 (suppl 1): 134-43.
72. Gulmezoglu AM, Crowther CA, Middleton P. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev 2006; 4: CD004945.
73. Imdad A, Bautista RMM, Senen KAA, Uy MEV, Mantaring JB 3rd, Bhutta ZA. Umbilical cord antiseptics for preventing sepsis and death among newborns. Cochrane Database Syst Rev 2013; 5: CD008635.
74. WHO recommendations on postnatal care of the mother and newborn. 2013. http://www.healthynewbornnetwork.org/resource/who-recommendations-postnatal- care-mother-and-newborn-2013 (accessed March 30, 2014).
75. Rabe H, Diaz-Rossello JL, Duley L, Dowswell T. Effect of timing of umbilical cord clamping and other strategies to infl uence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012; 8: CD003248.
76. World Health Organization. The optimal duration of exclusive breastfeeding: report of an expert consultation. http://www.who.int/nutrition/ publications/infantfeeding/WHO-NHD-01.09/en/index.html (accessed Jan 25, 2014).
77. Debes AK, Kohli A, Walker N, Edmond K, Mullany LC. Time to initiation of breastfeeding and neonatal mortality and morbidity: A systematic review. BMC Public Health 2013; 13 (suppl 3): S19.
78. Haroon S, Das JK, Salam RA, Imdad A, Bhutta ZA. Breastfeeding promotion interventions and breastfeeding practices: A systematic review. BMC Public Health 2013; 13 (suppl 3): S20.
79. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007; 4: CD000501.
80. Haider BA, Bhutta ZA. Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in developing countries. Cochrane Database Syst Rev 2011; 10: CD006980.
81. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev 2000; 4: CD002776.
82. Lawn JE, Mwansa-Kambafwile J, Horta BL, Barros FC, Cousens S. 'Kangaroo mother care' to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol 2010; 39 (suppl 1): 144-54.
83. Conde-Agudelo A, Belizan JM, Diaz-Rossello J. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2011; 3: CD002771.
84. Moore ER, Anderson GC, Bergman N. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev 2007; 3: CD003519.
85. Lee AC, Cousens S, Wall SN, et al. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: A systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health 2011; 11 (suppl 3): S12.
86. Evans DJ, Levene MI, Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev 2007; 3: CD001240.
87. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; 1: CD003311.
88. Pauliah SS, Shankaran S, Wade A, Cady EB, Thayyil S. Therapeutic hypothermia for neonatal encephalopathy in low- and middleincome countries: A systematic review and meta-analysis. PLoS One 2013; 8: E58834.
89. Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002; 2: CD002271.
90. Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008; 63: 395-401.
91. Kawaza K, Machen HE, Brown J, et al. Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi. PLoS One 2014; 9: E86327.
92. Soll R, Ozek E. Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1997; 4: CD000511.
93. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009; 2: CD007836.
94. Bhutta ZA, Khan I, Salat S, Raza F, Ara H. Reducing length of stay in hospital for very low birthweight infants by involving mothers in a stepdown unit: An experience from Karachi (Pakistan). BMJ 2004; 329: 1151-55.
95. Zaidi AKM, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11 (suppl 3): S13.
96. Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev 2011; 12: CD007969.
97. Salam RA, Das JK, Darmstadt GL, Bhutta ZA. Emollient therapy for preterm newborn infants-evidence from the developing world. BMC Public Health 2013; 13 (suppl 3): S31.
98. Lassi ZS, Haider BA, Bhutta ZA. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes. Cochrane Database Syst Rev 2010; 11: CD007754.
99. Bang AT, Bang RA, Baitule SB, Reddy MH, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: Field trial in rural India. Lancet 1999; 354: 1955-61.
100. Baqui AH, El-Arifeen S, Darmstadt GL, et al, and the Projahnmo Study Group. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: A cluster-randomised controlled trial. Lancet 2008; 371: 1936-44.
101. Carlo WA, Goudar SS, Jehan I, et al, and the First Breath Study Group. Newborn-care training and perinatal mortality in developing countries. N Engl J Med 2010; 362: 614-23.
102. Prost A, Colbourn T, Seward N, et al. Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: A systematic review and meta-analysis. Lancet 2013; 381: 1736-46.
103. UNICEF. Child Health Days 1999-2009: Key achievements and the way forward. A report prepared for the UNICEF Joint Working Group on Child Health Days. New York: UNICEF, 2011.
104. Darmstadt GL, Baqui AH, Choi Y, et al, and the Bangladesh Projahnmo-2 (Mirzapur) Study. Validation of a clinical algorithm to identify neonates with severe illness during routine household visits in rural Bangladesh. Arch Dis Child 2011; 96: 1140-46.
105. Mittal K, Gupta V, Khanna P, Kaushik JS, Sharma A. Evaluation of Integrated Management of Neonatal and Childhood Illness (IMNCI) algorithm for diagnosis and referral in under-fi ve children. Indian J Pediatr 2013; published online Oct 1. DOI:10.1007/s12098- 013-1225-2.
106. Bhandari N, Mazumder S, Taneja S, Sommerfelt H, Strand TA; IMNCI Evaluation Study Group. Effect of implementation of Integrated Management of Neonatal and Childhood Illness (IMNCI) programme on neonatal and infant mortality: cluster randomised controlled trial. BMJ 2012; 344: E1634.
107. Armstrong Schellenberg JR, Adam T, Mshinda H, et al. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet 2004; 364: 1583-94.
108. Zaidi S, Bhutta ZA. Result based financial mechanisms for improving maternal, newborn and child health outputs. http://mother-childlink.tghn.org/ articles/result-based-financialmechanisms-improving-maternal-newborn-and-child- healthoutputs/(accessed Dec 30, 2013).
109. Amudhan S, Mani K, Rai SK, Pandav CS, Krishnan A. Effectiveness of demand and supply side interventions in promoting institutional deliveries-a quasi-experimental trial from rural north India. Int J Epidemiol 2013; 42: 769-80.
110. Lim SS, Dandona L, Hoisington JA, James SL, Hogan MC, Gakidou E. India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: An impact evaluation. Lancet 2010; 375: 2009-23.
111. Robertson L, Mushati P, Eaton JW, et al. Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: A cluster-randomised trial. Lancet 2013; 381: 1283-92.
112. Friberg IK, Kinney MV, Lawn JE, et al, and the Science in Action: Saving the Lives of Africa's Mothers, Newborns, and Children working group. Sub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions? PLoS Med 2010; 7: E1000295.
113. PLoS Medicine Editors. Maternal health: Time to deliver. PLoS Med 2010; 7: E1000300.
114. Althabe F, Bergel E, Cafferata ML, et al. Strategies for improving the quality of health care in maternal and child health in low- and middle-income countries: An overview of systematic reviews. Paediatr Perinat Epidemiol 2008; 22 (suppl 1): 42-60.
115. van den Broek NR, Graham WJ. Quality of care for maternal and newborn health: The neglected agenda. BJOG 2009; 116 (suppl 1): 18-21.
116. Wagaarachchi PT, Fernando L. Trends in maternal mortality and assessment of substandard care in a tertiary care hospital. Eur J Obstet Gynecol Reprod Biol 2002; 101: 36-40.
117. vers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: Effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012; 6: CD000259.
118. Opiyo N, English M. In-service training for health professionals to improve care of the seriously ill newborn or child in low and middle-income countries. Cochrane Database Syst Rev 2010; 4: CD007071.
119. Msemo G, Massawe A, Mmbando D, et al. Newborn mortality and fresh stillbirth rates in Tanzania after helping babies breathe training. Pediatrics 2013; 131: 353-60.
120. Witter S, Fretheim A, Kessy FL, Lindahl AK. Paying for performance to improve the delivery of health interventions in low- and middleincome countries. Cochrane Database Syst Rev 2012; 2: CD007899.
121. Spector JM, Agrawal P, Kodkany B, et al. Improving quality of care for maternal and newborn health: prospective pilot study of the WHO safe childbirth checklist program. PLoS One 2012; 7: E35151.
122. Balas EA, Jaffrey F, Kuperman GJ, et al. Electronic communication with patients. Evaluation of distance medicine technology. JAMA 1997; 278: 152-59.
123. Tan K, Lai NM. Telemedicine for the support of parents of high-risk newborn infants. Cochrane Database Syst Rev 2012; 6: CD006818.
124. Hodnett ED, Fredericks S, Weston J. Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database Syst Rev 2010; 6: CD000198.
125. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C, Weston J. Continuous support for women during childbirth. Cochrane Database Syst Rev 2011; 2: CD003766.
126. Renfrew MJ, McCormick FM, Wade A, Quinn B, Dowswell T. Support for healthy breastfeeding mothers with healthy term babies. Cochrane Database Syst Rev 2012; 5: CD001141.
127. Stenberg K, Axelson H, Sheehan P, et al, and the Study Group for the Global Investment Framework for Women's Children's Health. Advancing social and economic development by investing in women's and children's health: A new Global Investment Framework. Lancet 2014; 383: 1333-54.
128. Bhutta ZA, Das JK, Walker N, et al, and the Lancet Diarrhoea and Pneumonia Interventions Study Group. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet 2013; 381: 1417-29.
129. Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW. Can the world afford to save the lives of 6 million children each year? Lancet 2005; 365: 2193-200.
130. Lawn J. The price tag for newborn and child survival. Tracking progress in child survival: countdown to 2015; University of London, London, UK; Dec 13-14, 2005.
131. WHO. World health report 2005: make every mother and child count. Geneva: World Health Organization, 2005.
132. Singh S, Darroch JE, Ashford LS, Vlassoff M. Adding it up: The costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and UN Population Fund, 2009.
133. Guttmacher Institute. Facts on investing in family planning and maternal and newborn health. http://www.guttmacher.org/pubs/FB-AIU-summary.pdf (accessed April 25, 2014).
134. Taskforce for innovative international financing for health systems. More money for health, and more health for the money. London: International Health Partnership, 2009.
135. WHO Commission on Macroeconomics and Health. Improving health outcomes of the poor: The report of Working Group 5 of the Commission on Macroeconomics and Health. Geneva: World Health Organization, 2002.
136. Bhutta ZA, Darmstadt GL, Hasan BS, Haws RA. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: A review of the evidence. Pediatrics 2005; 115 (suppl): 519-617.
137. The Partnership for Maternal Health, Newborn and Child Health and the Aga Khan University. Essential interventions, commodities and guidelines for reproductive, maternal, newborn and child health: A global review of the key interventions related to reproductive, maternal, newborn and child Health. http://www.who.int/pmnch/topics/part-publications/essential-interventions-18-01- 2012.pdf (accessed 15 Jan, 2014).
138. Bhutta ZA, Black RE. Global maternal, newborn, and child health- so near and yet so far. N Engl J Med 2013; 369: 2226-35.
139. Mason E, McDougall L, Lawn JE, et al, for The Lancet Every Newborn Study Group, on behalf of the Every Newborn Steering Committee. From evidence to action to deliver a healthy start for the next generation. Lancet 2014; published online May 20. http://dx.doi.org/10.1016/S0140-6736(14)60750-9.
140. Martines J, Paul VK, Bhutta ZA, et al, and The Lancet Neonatal Survival Steering Team. Neonatal survival: A call for action. Lancet 2005; 365: 1189-97.
141. Victora CG, Barros AJ, Axelson H, et al. How changes in coverage affect equity in maternal and child health interventions in 35 Countdown to 2015 countries: An analysis of national surveys. Lancet 2012; 380: 1149-56.
142. Homer CSE, Friberg IK, Bastos Dias MA, et al. The projected impact of scaling up midwifery. Lancet (in press).
143. Dickson KE, Simen-Kapeu A, Kinney MV, et al. Health-systems bottlenecks and strategies to accelerate scale-up in countries. Lancet 2014; published online May 20. http://dx.doi.org/10.1016/S0140-6736(14)60582-1.